Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Phase I, Dose escalation • determination of the maximum tolerated dose (MTD) of FBTA05 in patients with relapsed or refractory chronic lymphocytic leukemia (B-CLL). Phase II, Efficacy • evaluation of the preliminary efficacy of FBTA05 in patients with relapsed or refractory chronic lymphocytic leukemia with regard to objective response rate (CR, PR)
Critère d'inclusion
- Relapsed or Refractory Chronic Lymphocytic Leukemia